Treatment of mastitis in dairy cows
Introducing the drug of Pfizer for the treatment of mastitis in dairy cows
To date, most anti-mastitis drugs have been developed for Streptococcus aureus and Staphylococcus aureus. Recently, the pharmaceutical company pfizer introduced the drug \”Spectramast LC\” (Ceftiophore Hydrochloride), which is a sterile solution for the treatment of this disease.
It is actually an intramammary product for the treatment of clinical mastitis in dairy cows, which is caused by the disease, E. coli staphylococcus coagulase-negative bacteria and strep dysgalactia.
When discussing clinical mastitis, gram-negative bacteria are often considered because they are inherently more resistant to drug treatment than gram-positive bacteria. Because of this resistance, gram-negative bacteria can cause more severe mastitis, which eventually leads to miscarriage and abortion.
Introducing the terms gram-positive and gram-negative bacteria
Gram-positive and gram-negative are classifications of bacteria based on a laboratory staining method. Due to the difference in the cell wall of gram-negative bacteria with gram-positive bacteria, they respond differently to staining, causing them to react differently to different antibiotics.
Many environmental bacteria are classified as gram-negative bacteria.
Environmental pathogens are commonly found in feces, bedding, food, dust, soil and water.
As you have experienced, “environmental pathogens are difficult to control. Because they are always present in the environment around the cow. The key to controlling these pathogens is keeping the cow clean, dry, and comfortable, as well as following an antibiotic treatment program.